Multivariable models for clinical risk factors
| . | Day 28 nonresponse . | Day 180 survival . | Day 180 nonrelapse mortality . | |||
|---|---|---|---|---|---|---|
| Variable . | OR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
| Initial liver GVHD | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 7.11 (2.86-17.7) | <.001 | 5.18 (2.67-10.1) | <.001 | 7.07 (3.25-15.4) | <.001 |
| Acute GVHD initial grade | ||||||
| 1-2 | 1 | 1 | 1 | |||
| 3 | 2.52 (1.24-5.14) | .011 | 2.22 (1.14-4.32) | .019 | 2.74 (1.23-6.12) | .014 |
| Age | ||||||
| <50 y | 1 | 1 | 1 | |||
| ≥50 y | 2.13 (1.10-4.15) | .026 | 1.66 (0.89-3.09) | .11 | 1.46 (0.71-2.99) | .30 |
| Donor | ||||||
| Matched sibling | — | 1 | 1 | |||
| Others | — | 2.00 (0.83-4.82) | .12 | 1.99 (0.68-5.81) | .21 | |
| . | Day 28 nonresponse . | Day 180 survival . | Day 180 nonrelapse mortality . | |||
|---|---|---|---|---|---|---|
| Variable . | OR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
| Initial liver GVHD | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 7.11 (2.86-17.7) | <.001 | 5.18 (2.67-10.1) | <.001 | 7.07 (3.25-15.4) | <.001 |
| Acute GVHD initial grade | ||||||
| 1-2 | 1 | 1 | 1 | |||
| 3 | 2.52 (1.24-5.14) | .011 | 2.22 (1.14-4.32) | .019 | 2.74 (1.23-6.12) | .014 |
| Age | ||||||
| <50 y | 1 | 1 | 1 | |||
| ≥50 y | 2.13 (1.10-4.15) | .026 | 1.66 (0.89-3.09) | .11 | 1.46 (0.71-2.99) | .30 |
| Donor | ||||||
| Matched sibling | — | 1 | 1 | |||
| Others | — | 2.00 (0.83-4.82) | .12 | 1.99 (0.68-5.81) | .21 | |
CB, cord blood; BM, bone marrow; OR, odds ratio; PB, peripheral blood.